Celldex Therapeutics | CLDX - Current Assets

Stock Price
29.51
Daily Change
4.67 18.78%
Monthly
11.05%
Yearly
41.85%
Q1 Forecast
22.31

Celldex Therapeutics reported $604.34M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
AbbVie USD 29.06B 523M Dec/2025
Agenus USD 133.95M 120.61M Sep/2025
Amgen USD 29.06B 1.17B Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Celldex Therapeutics USD 604.34M 44.06M Sep/2025
Glaxosmithkline GBP 23.98B 6.31B Sep/2025
Nektar Therapeutics USD 281.36M 94.79M Sep/2025
Northwest Biotherapeutics USD 7.2M 1.04M Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Rigel Pharmaceuticals USD 214.93M 39.53M Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025